Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating a tumor expressing carbonic anhydrase IX (G250) by administering a G250-specific chimeric antigen receptor

Method of treating a tumor expressing carbonic anhydrase IX (G250) by administering a G250-specific chimeric antigen receptor

US Patent 12024567 · Granted Jul 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against MUC12025
Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof2025
Engineered cells, T cell immune modulating antibodies and methods for using the 2025
Chimeric antigen receptors and methods of use thereof2025
Humanized influenza monoclonal antibodies and methods of use thereof2024
Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof2023
Middle east respiratory syndrome coronavirus neutralizing antibodies and methods2022
Methods for depleting or inhibiting the migration of regulatory T-cells in early2022
Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies2021
Humanized influenza monoclonal antibodies and methods of use thereof2021
Immunogenetic restriction on elicitation of antibodies2021
Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and meth2021